Formalizing drug indications on the road to therapeutic intent.

Publication Date

11-1-2017

Abstract

Therapeutic intent, the reason behind the choice of a therapy and the context in which a given approach should be used, is an important aspect of medical practice. There are unmet needs with respect to current electronic mapping of drug indications. For example, the active ingredient sildenafil has 2 distinct indications, which differ solely on dosage strength. In progressing toward a practice of precision medicine, there is a need to capture and structure therapeutic intent for computational reuse, thus enabling more sophisticated decision-support tools and a possible mechanism for computer-aided drug repurposing. The indications for drugs, such as those expressed in the Structured Product Labels approved by the US Food and Drug Administration, appears to be a tractable area for developing an application ontology of therapeutic intent.

ISSN

1527-974X

Document Type

Article

Publisher

Hanley & Belfus

Keywords

Drug Labeling, Drug Repositioning, Drug Therapy, Humans, Precision Medicine, United States, United States Food and Drug Administration, Vocabulary, Controlled

Publication Title

Journal of the American Medical Informatics Association : JAMIA

Link to Full Text

Share

COinS